Guest guest Posted March 3, 2010 Report Share Posted March 3, 2010 Article Date: 01 Mar 2010 " Huixin He, associate professor of nanoscale chemistry at Rutgers University, Newark, and Tamara Minko, professor at the Rutgers Ernest School of Pharmacy, have developed a nanotechnology approach that could potentially eliminate the problems of side effects and drug resistance in the treatment of cancer. Under traditional chemotherapy, cancer cells, like bacteria, can develop resistance to drug therapy, leading to a relapse of the disease. " As reported in the December 21, 2009, issue of the journal Small, He, Minko and their co-researchers, including investigators from Merck & Co. and Carl Zeiss SMT, a global nanotechnology firm, have designed nanomaterials that allow for the delivery of both a chemical (doxorubicin) to destroy cancer cells and a genetic drug to prevent drug resistance. " When administered to drug-resistant ovarian cancer cells, the treatment was more than 130 times lethal than when doxorubicin was administrated alone. " The drug can only be released when it is inside the cancer cells, " He said. " This controlled internal release mechanism can dramatically eliminate side effects associated with anticancer drugs to normal tissues. " More on this subject at this website: http://www.medicalnewstoday.com/articles/180586.php FYI, Lottie Duthu Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.